These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 8450517

  • 1. Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension.
    Landmark K, Thaulow E, Hysing J, Mundal HH, Eritsland J, Hjermann I.
    J Hum Hypertens; 1993 Feb; 7(1):25-32. PubMed ID: 8450517
    [Abstract] [Full Text] [Related]

  • 2. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC, Minihane AM, Leake DS, Wright JW, Murphy MC, Griffin BA, Williams CM.
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [Abstract] [Full Text] [Related]

  • 3. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 May; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 4. Effect of fish oil on blood pressure and serum lipids in hypertension and hyperlipidaemia.
    Steiner A, Oertel R, Bättig B, Pletscher W, Weiss B, Greminger P, Vetter W.
    J Hypertens Suppl; 1989 May; 7(3):S73-6. PubMed ID: 2547916
    [Abstract] [Full Text] [Related]

  • 5. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
    Bairati I, Roy L, Meyer F.
    Can J Cardiol; 1992 May; 8(1):41-6. PubMed ID: 1617510
    [Abstract] [Full Text] [Related]

  • 6. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 May; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia.
    Bunea R, El Farrah K, Deutsch L.
    Altern Med Rev; 2004 Dec; 9(4):420-8. PubMed ID: 15656713
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [Abstract] [Full Text] [Related]

  • 9. Fish oil as an adjuvant in the treatment of hypertension.
    Gray DR, Gozzip CG, Eastham JH, Kashyap ML.
    Pharmacotherapy; 1996 Jul; 16(2):295-300. PubMed ID: 8820475
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 11. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [Abstract] [Full Text] [Related]

  • 12. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.
    Yosefy C, Viskoper JR, Varon D, Ilan Z, Pilpel D, Lugassy G, Schneider R, Savyon N, Adan Y, Raz A.
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S135-9. PubMed ID: 8872845
    [Abstract] [Full Text] [Related]

  • 13. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL, Mensink RP.
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [Abstract] [Full Text] [Related]

  • 14. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.
    Bowden RG, Wilson RL, Deike E, Gentile M.
    Nutr Clin Pract; 2009 Aug; 24(4):508-12. PubMed ID: 19461006
    [Abstract] [Full Text] [Related]

  • 15. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
    Agren JJ, Hänninen O, Julkunen A, Fogelholm L, Vidgren H, Schwab U, Pynnönen O, Uusitupa M.
    Eur J Clin Nutr; 1996 Nov; 50(11):765-71. PubMed ID: 8933125
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER, Botero R, Octavio JA, Berrizbeitia ML, Mayorca E, Castro P, Miranda R, Valecillo E, Aroca G, Aza G, González M.
    Am J Ther; 2007 Nov; 14(2):140-6. PubMed ID: 17414581
    [Abstract] [Full Text] [Related]

  • 17. [Effect on the lipid profile of diet supplemented with fish oil concentrate].
    Bøhn KA, Friisk CF, Bøe OW, Hysing J.
    Tidsskr Nor Laegeforen; 1990 May 20; 110(13):1693-6. PubMed ID: 2195704
    [Abstract] [Full Text] [Related]

  • 18. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
    Castro IA, Monteiro VC, Barroso LP, Bertolami MC.
    Nutrition; 2007 Feb 20; 23(2):127-37. PubMed ID: 17234506
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 20; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 20. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.
    Radack K, Deck C, Huster G.
    Arch Intern Med; 1991 Jun 20; 151(6):1173-80. PubMed ID: 1828336
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.